ATE267816T1 - Tan-1057 derivate - Google Patents

Tan-1057 derivate

Info

Publication number
ATE267816T1
ATE267816T1 AT99968234T AT99968234T ATE267816T1 AT E267816 T1 ATE267816 T1 AT E267816T1 AT 99968234 T AT99968234 T AT 99968234T AT 99968234 T AT99968234 T AT 99968234T AT E267816 T1 ATE267816 T1 AT E267816T1
Authority
AT
Austria
Prior art keywords
derivatives
tan
disorders
humans
animals
Prior art date
Application number
AT99968234T
Other languages
German (de)
English (en)
Inventor
Michael Brands
Mazen Es-Sayed
Dieter Haebich
Siegfried Raddatz
Joachim Krueger
Rainer Endermann
Reinhold Gahlmann
Hein-Peter Kroll
Frank-Ulrich Geschke
Meijere Armin De
Vladimir N Belov
Victor Sokolov
Sergej Kozhushkov
Markus Kordes
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE267816T1 publication Critical patent/ATE267816T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
AT99968234T 1998-08-27 1999-08-20 Tan-1057 derivate ATE267816T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19838998A DE19838998A1 (de) 1998-08-27 1998-08-27 Neue Naturstoffderivate
PCT/EP1999/006124 WO2000012484A1 (de) 1998-08-27 1999-08-20 Tan-1057 derivate

Publications (1)

Publication Number Publication Date
ATE267816T1 true ATE267816T1 (de) 2004-06-15

Family

ID=7878913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968234T ATE267816T1 (de) 1998-08-27 1999-08-20 Tan-1057 derivate

Country Status (25)

Country Link
US (1) US6617332B1 (enExample)
EP (1) EP1117652B1 (enExample)
JP (1) JP4533535B2 (enExample)
KR (1) KR20010099629A (enExample)
CN (1) CN1324348A (enExample)
AT (1) ATE267816T1 (enExample)
AU (1) AU759618B2 (enExample)
BG (1) BG105275A (enExample)
BR (1) BR9913337A (enExample)
CA (1) CA2342102C (enExample)
DE (2) DE19838998A1 (enExample)
EE (1) EE200100125A (enExample)
ES (1) ES2219105T3 (enExample)
HK (1) HK1041884A1 (enExample)
HR (1) HRP20010135A2 (enExample)
HU (1) HUP0103316A3 (enExample)
ID (1) ID28365A (enExample)
IL (1) IL141325A0 (enExample)
NO (1) NO20010940L (enExample)
NZ (1) NZ510153A (enExample)
PL (1) PL346143A1 (enExample)
SK (1) SK2622001A3 (enExample)
TR (1) TR200100637T2 (enExample)
WO (1) WO2000012484A1 (enExample)
ZA (1) ZA200101038B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113008A1 (en) * 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
US20040204404A1 (en) * 2002-09-30 2004-10-14 Robert Zelle Human N-type calcium channel blockers
US8309724B2 (en) * 2007-12-20 2012-11-13 Dr. Reddy's Laboratories Limited Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
WO2011046007A1 (ja) 2009-10-15 2011-04-21 国立大学法人徳島大学 ジエチレントリアミン五酢酸誘導体の製造方法およびジエチレントリアミン五酢酸誘導体
CN102725274A (zh) * 2009-10-16 2012-10-10 Rib-X制药公司 抗微生物化合物和其制备和使用方法
NZ599289A (en) 2009-10-16 2014-11-28 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
KR20190044136A (ko) 2009-10-16 2019-04-29 멜린타 서브시디어리 코프. 항미생물성 화합물 및 이의 제조 방법 및 사용 방법
KR20120099435A (ko) * 2009-10-16 2012-09-10 립-엑스 파마슈티칼즈, 인크. 항미생물성 화합물 및 이의 제조 방법 및 사용 방법
EA201391536A1 (ru) 2011-04-15 2014-08-29 Мелинта Терапьютикс, Инк. Противомикробные соединения и способы их получения и применения
RU2475479C1 (ru) * 2011-12-23 2013-02-20 Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) Вазоконстрикторное средство
SG10201801956SA (en) 2013-09-09 2018-04-27 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
EP3038623A4 (en) 2013-09-09 2017-04-19 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
JP2018507881A (ja) 2015-03-11 2018-03-22 メリンタ セラピューティクス,インコーポレイテッド 抗微生物化合物ならびにこれらを作製および使用する方法
CA3023317A1 (en) 2016-05-06 2017-11-09 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質tan―1057,その製造法および用途
US6110925A (en) 1997-08-07 2000-08-29 Research Corporation Technologies, Inc. Antibiotic for methicillin resistant bacteria

Also Published As

Publication number Publication date
JP4533535B2 (ja) 2010-09-01
WO2000012484A1 (de) 2000-03-09
ES2219105T3 (es) 2004-11-16
CA2342102A1 (en) 2000-03-09
HK1041884A1 (zh) 2002-07-26
AU759618B2 (en) 2003-04-17
ZA200101038B (en) 2002-02-07
DE19838998A1 (de) 2000-03-09
US6617332B1 (en) 2003-09-09
EP1117652B1 (de) 2004-05-26
ID28365A (id) 2001-05-17
HRP20010135A2 (en) 2002-02-28
NZ510153A (en) 2002-12-20
BR9913337A (pt) 2001-05-15
IL141325A0 (en) 2002-03-10
EE200100125A (et) 2002-06-17
NO20010940D0 (no) 2001-02-23
NO20010940L (no) 2001-04-23
BG105275A (en) 2001-11-30
PL346143A1 (en) 2002-01-28
CA2342102C (en) 2008-10-28
EP1117652A1 (de) 2001-07-25
HUP0103316A2 (hu) 2002-04-29
AU1009900A (en) 2000-03-21
JP2002523496A (ja) 2002-07-30
HUP0103316A3 (en) 2002-06-28
KR20010099629A (ko) 2001-11-09
SK2622001A3 (en) 2001-11-06
TR200100637T2 (tr) 2001-10-22
DE59909607D1 (de) 2004-07-01
CN1324348A (zh) 2001-11-28

Similar Documents

Publication Publication Date Title
MY124122A (en) Heterocyclic derivatives
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
DK1200418T3 (da) Nematodicide trifluorbutener
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TR200001542T2 (tr) Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri.
GB9715894D0 (en) Heterocyclic derivatives
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
ATE267816T1 (de) Tan-1057 derivate
MY115211A (en) Novel amino acid derivatives, their preparation and use
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
BG106155A (en) Novel derivatives and analogues of galanthamin
GB9809349D0 (en) Heterocyclic derivatives
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
MXPA04005552A (es) Analogos de vitamina d.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
DE60003074D1 (de) Fusidinsäure-derivate
SE9803277D0 (sv) Novel compounds
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee